Bates SE - Search Results

1

Camptothecin resistance: role of the ATP-binding cassette (ABC), mitoxantrone-resistance half-transporter (MXR), and potential for glucuronidation in MXR-expressing cells.

Brangi M, Litman T, Ciotti M, Nishiyama K, Kohlhagen G, Takimoto C, Robey R, Pommier Y, Fojo T, Bates SE. Brangi M, et al. Among authors: bates se. Cancer Res. 1999 Dec 1;59(23):5938-46. Cancer Res. 1999. PMID: 10606239

2

Various methods of analysis of mdr-1/P-glycoprotein in human colon cancer cell lines.

Herzog CE, Trepel JB, Mickley LA, Bates SE, Fojo AT. Herzog CE, et al. Among authors: bates se. J Natl Cancer Inst. 1992 May 6;84(9):711-6. doi: 10.1093/jnci/84.9.711. J Natl Cancer Inst. 1992. PMID: 1349044

3

Contribution of glutathione and glutathione-dependent enzymes in the reversal of adriamycin resistance in colon carcinoma cell lines.

Lai GM, Moscow JA, Alvarez MG, Fojo AT, Bates SE. Lai GM, et al. Among authors: bates se. Int J Cancer. 1991 Nov 11;49(5):688-95. doi: 10.1002/ijc.2910490511. Int J Cancer. 1991. PMID: 1682279

4

P-glycoprotein expression and schedule dependence of adriamycin cytotoxicity in human colon carcinoma cell lines.

Lai GM, Chen YN, Mickley LA, Fojo AT, Bates SE. Lai GM, et al. Among authors: bates se. Int J Cancer. 1991 Nov 11;49(5):696-703. doi: 10.1002/ijc.2910490512. Int J Cancer. 1991. PMID: 1682280

5

Molecular targets in the National Cancer Institute drug screen.

Bates SE, Fojo AT, Weinstein JN, Myers TG, Alvarez M, Pauli KD, Chabner BA. Bates SE, et al. J Cancer Res Clin Oncol. 1995;121(9-10):495-500. doi: 10.1007/BF01197759. J Cancer Res Clin Oncol. 1995. PMID: 7559726 Review. No abstract available.

6

Reversal of multidrug resistance.

Bates SE, Zhan Z, Dickstein B, Lee JS, Scala S, Fojo AT, Paull K, Wilson W. Bates SE, et al. Prog Clin Biol Res. 1994;389:33-7. Prog Clin Biol Res. 1994. PMID: 7700913 Review. No abstract available.

7

Molecular diagnosis of multidrug resistance.

Herzog CE, Bates SE. Herzog CE, et al. Among authors: bates se. Cancer Treat Res. 1994;73:129-47. doi: 10.1007/978-1-4615-2632-2_7. Cancer Treat Res. 1994. PMID: 7710903 Review. No abstract available.

8

Chemoresistance in the clinic: overview 1994.

Bates SE, Regis JI, Robey RW, Zhan Z, Scala S, Meadows BJ. Bates SE, et al. Bull Cancer. 1994 Dec;81 Suppl 2:55s-61s. Bull Cancer. 1994. PMID: 7727860 Review.

9

Generation of a drug resistance profile by quantitation of mdr-1/P-glycoprotein in the cell lines of the National Cancer Institute Anticancer Drug Screen.

Alvarez M, Paull K, Monks A, Hose C, Lee JS, Weinstein J, Grever M, Bates S, Fojo T. Alvarez M, et al. J Clin Invest. 1995 May;95(5):2205-14. doi: 10.1172/JCI117910. J Clin Invest. 1995. PMID: 7738186 Free PMC article.

10

Normal p53 status and function despite the development of drug resistance in human breast cancer cells.

Wosikowski K, Regis JT, Robey RW, Alvarez M, Buters JT, Gudas JM, Bates SE. Wosikowski K, et al. Among authors: bates se. Cell Growth Differ. 1995 Nov;6(11):1395-403. Cell Growth Differ. 1995. PMID: 8562478

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

419 results

Search Page

Filters